All
Institute of Medicine Recommends FDA Revisit Biomarker Standards
September 20th 2010The Institute of Medicine (IOM; Washington, DC) has released a report urging FDA to standardize its methods for validating biomarkers used in scientific studies. IOM says that right now, FDA is hampered in its ability to evaluate proposed health claims because it lacks a process for validating biomarkers.
Maternal Vitamin A Supplementation Improves Lung Function in Children
September 20th 2010Vitamin A may have a positive effect on adolescent lung function, according to a study in The New England Journal of Medicine'”but only if a mother takes it. From 1994 to 1997, pregnant Nepalese women participated in a placebo-controlled, double-blind, cluster-randomized trial in which they supplemented with vitamin A, beta-carotene, or placebo.
Artinia Declared Safe by EFSA Panel
September 20th 2010Stratum Nutrition’s (St. Louis) Artinia chitin-glucan fiber, targeting arterial and heart health, has been determined safe as a novel food ingredient by the European Food Safety Authority’s (EFSA) panel on Dietetic Products, Nutrition, and Allergies (DNA).
Dairy Research Institute Formed
September 20th 2010The Dairy Research Institute has been founded by Dairy Management Inc. (DMI; Rosemont, IL) and the Innovation Center for U.S. Dairy. The nonprofit institute is designed to help strengthen the dairy industry’s access to and investment in technical research for dairy innovation. It will work with industry, academic, government, and commercial partners to promote precompetitive research.
PepsiCo to Develop Sweeteners for Low-Calorie Drinks
September 20th 2010PepsiCo announced a four-year partnership with flavors firm Senomyx Inc. (San Diego, CA) to develop and commercialize natural sweeteners and sweetness enhancers. New discoveries will be used to lower the calorie content of future PepsiCo beverages.
Chinese Chondroitin Certified for Quality
September 20th 2010Yantai Dongcheng Biochemicals Co.’s (Yantai, China) chondroitin sulfate has received a Certificate of Suitability (COS) from the European Directorate for the Quality of Medicines & Healthcare. The certificate indicates that the chondroitin sulfate complies with European Pharmacopeia standards.